The company offers metabolite profiling and bioinformatic analysis services for drug research, clinical diagnostics, and personalized medicine. They provide TrueMass Profiling, which quantifies metabolites involved in lipid metabolism, fatty acid oxidation, and cholesterol metabolism. Lipomics also offers TrueView Display, a suite of tools for visualizing and displaying data. Founded in 2000, Lipomics operates as a subsidiary of Tethys BioScience and was acquired by Metabolon in 2012. They specialize in metabolomics for drug development and biomarker discovery.